MyAverix Finance MyAverix Finance

LSE · Healthcare

4BASEBIO UK SOCIETAS (4BB)

Biotechnology

4BASEBIO UK SOCIETAS (4BB) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 4BB

P/E ratio
18.00

4BASEBIO UK SOCIETAS (4BB) — FAQ

What is 4BB's P/E ratio?

The price-to-earnings (P/E) ratio for 4BASEBIO UK SOCIETAS (4BB) is 18.00 (data as of 2026-03-23).

Does 4BASEBIO UK SOCIETAS pay a dividend?

Dividend yield is not available in the current snapshot for 4BASEBIO UK SOCIETAS (4BB). Check the MyAverix Finance app for the latest dividend data.

What sector is 4BASEBIO UK SOCIETAS in?

4BASEBIO UK SOCIETAS (4BB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4BB listed on?

4BB is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play